Literature DB >> 1281748

Synaptic plasticity in the dentate gyrus of aged rats is altered after chronic nimodipine application.

G I de Jong1, B Buwalda, T Schuurman, P G Luiten.   

Abstract

We examined ultrastructural correlates of synaptic plasticity in the hippocampus of young (3 months) vs aged (30 months) Wistar rats and established the effects of the calcium antagonist nimodipine in animals chronically treated from 24 to 30 months. The effects of nimodipine was studied since this compound improves hippocampal neuronal physiology and enhances cognitive function during aging. In the supragranular layer of the dentate gyrus we found a 24% decrease in synaptic density (Nv) in aged animals, while synaptic size (S) was not significantly altered. After nimodipine treatment Nv in aged rats was not significantly different from young adults, thus being significantly increased compared to age-matched controls. The size of synapses was not significantly altered after nimodipine administration. Total synaptic surface area (Sv) in nimodipine-treated animals was significantly increased compared to aged controls, however, Sv remained significantly lower than in young adults. These data indicate that chronic administration of nimodipine enables granular cells in the dentate gyrus to maintain its number of synaptic contacts during the aging process. Furthermore, the presented influence of nimodipine on synaptic plasticity processes may underlie previously reported improved cognitive functioning of aged animals treated similarly with nimodipine.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1281748     DOI: 10.1016/0006-8993(92)91570-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

1.  Development of high throughput screening assays and pilot screen for inhibitors of metalloproteases meprin α and β.

Authors:  Franck Madoux; Claudia Tredup; Timothy P Spicer; Louis Scampavia; Peter S Chase; Peter S Hodder; Gregg B Fields; Christoph Becker-Pauly; Dmitriy Minond
Journal:  Biopolymers       Date:  2014-09       Impact factor: 2.505

2.  Nimodipine fosters remyelination in a mouse model of multiple sclerosis and induces microglia-specific apoptosis.

Authors:  Andrea Schampel; Oleg Volovitch; Tobias Koeniger; Claus-Jürgen Scholz; Stefanie Jörg; Ralf A Linker; Erhard Wischmeyer; Marie Wunsch; Johannes W Hell; Süleyman Ergün; Stefanie Kuerten
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-05       Impact factor: 11.205

3.  Nimodipine activates TrkB neurotrophin receptors and induces neuroplastic and neuroprotective signaling events in the mouse hippocampus and prefrontal cortex.

Authors:  Janne Koskimäki; Nobuaki Matsui; Juzoh Umemori; Tomi Rantamäki; Eero Castrén
Journal:  Cell Mol Neurobiol       Date:  2014-09-10       Impact factor: 5.046

Review 4.  Neuronal dysfunction with aging and its amelioration.

Authors:  Susumu Ando
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2012       Impact factor: 3.493

5.  Discovery of an enzyme and substrate selective inhibitor of ADAM10 using an exosite-binding glycosylated substrate.

Authors:  Franck Madoux; Daniela Dreymuller; Jean-Phillipe Pettiloud; Radleigh Santos; Christoph Becker-Pauly; Andreas Ludwig; Gregg B Fields; Thomas Bannister; Timothy P Spicer; Mare Cudic; Louis D Scampavia; Dmitriy Minond
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

6.  Discovery and Optimization of Selective Inhibitors of Meprin α (Part II).

Authors:  Chao Wang; Juan Diez; Hajeung Park; Timothy P Spicer; Louis D Scampavia; Christoph Becker-Pauly; Gregg B Fields; Dmitriy Minond; Thomas D Bannister
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-27

7.  Discovery and Optimization of Selective Inhibitors of Meprin α (Part I).

Authors:  Shurong Hou; Juan Diez; Chao Wang; Christoph Becker-Pauly; Gregg B Fields; Thomas Bannister; Timothy P Spicer; Louis D Scampavia; Dmitriy Minond
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.